FDA data Registry peer set 1 peer FDA shortage listed

Alternatives to ramelteon

FDA shortage status is active for ramelteon; 1 same-class SPL records are listed below for registry comparison only.

Brand: Rozerem

Melatonin Receptor Agonist Prescription 1 alternative found

ramelteon class peers while FDA lists an active shortage

ramelteon (Rozerem) is on an FDA shortage listing while 1 other Melatonin Receptor Agonist SPL records remain in this registry peer set (class inventory 2). Labeled indication field for ramelteon: Ramelteon is used to treat insomnia when you have trouble falling asleep.

Top FAERS reaction fields for ramelteon total 3,198 reports across 10 reactions, set beside tasimelteon. Counts are exposure-weighted submissions, not per-patient risk.

About ramelteon

Ramelteon (Rozerem) is a prescription medicine that can help you fall asleep faster. It works by acting like a natural hormone in your brain that regulates sleep.

Used for: Ramelteon is used to treat insomnia when you have trouble falling asleep. It can help you fall asleep faster so you can get a better night's rest. Studies have shown it works for up to six months.

1 Melatonin Receptor Agonist peers (wide set)

Compare ramelteon vs tasimelteon side-by-side →

ramelteon vs tasimelteon · FAERS reaction fields

FAERS top-reaction field "Insomnia" shows the widest count spread between ramelteon and tasimelteon in this extract (339-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect ramelteon tasimelteon
Initial Insomnia 447 153
Somnolence 411 408
Middle Insomnia 390 412
Insomnia 388 727
Nausea 327 145
Fatigue 283 222
Dizziness 268 -
Headache 254 384

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

ramelteon shortage vs Melatonin Receptor Agonist peer index

Shortage status

FDA shortage listing is active for ramelteon (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for ramelteon while peers remain indexed?
Yes - ramelteon matched an active FDA shortage listing (To Be Discontinued) while 1 other Melatonin Receptor Agonist SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full ramelteon profile →

Field note for ramelteon: see also the generic vs brand label guide when reading Rozerem SPL strings.